Duvelisib Dosing Modification Does Not Comprom... - CLL Support

CLL Support

23,335 members40,042 posts

Duvelisib Dosing Modification Does Not Compromise Efficacy in Heavily Pretreated CLL/SLL

Jm954 profile image
Jm954Administrator
11 Replies

Reducing or interrupting duvelisib (Copiktra) treatment does not increase toxicity or reduce outcomes with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).

Furthermore, treatment with the PI3K inhibitor led to a superior median progression-free survival (PFS) compared with ofatumumab (Arzerra) while producing rapid and durable responses in heavily pretreated patients.

Results from 2 analyses of the phase III DUO trial presented as posters at the 2019 SOHO Annual Meeting suggest that duvelisib monotherapy is a viable therapy for a patient population that has limited treatment options.

Lots more information here: onclive.com/conference-cove...

Jackie

Written by
Jm954 profile image
Jm954
Administrator
To view profiles and participate in discussions please or .
Read more about...
11 Replies
PlanetaryKim profile image
PlanetaryKim

interesting! thanks for sharing.

HopeME profile image
HopeME

There is a Duvelisib/Venetoclax trial going on at Dana Farber for relapsed SLL/CLL. I haven’t heard much about Duvelisib lately. Thoughts on this trial? There is so much research going on it is confusing. I keep hoping that the research efforts lead to a silver bullet. Venetoclax always seems to be in the mix.

Best

Mark

Jm954 profile image
Jm954Administrator in reply toHopeME

Mark, Duvelisib seems more promising than Idelasilib and I’m not aware of any of the severe toxicity’s such as pneumonitis with it that were too common with Idelasilib.

The trial sounds a promising combination.

Jackie

Justasheet1 profile image
Justasheet1 in reply toJm954

Jackie,

I guess if you failed a BTK it would be good. Combo ‘s seem to look best. But these PI3k’s are third in line following ibrutinib or Acalabrutinib then Venetoclax.

Jeff

HopeME profile image
HopeME in reply toJustasheet1

Hi Jeff: Thanks for your comment. I agree that the medicines you mention are being relied upon more than Duvelisib, which seems to be used as a salvage therapy. That being said, I find it interesting that it is now paired with Venetoclax..

How are you feeling? Is your energy good? I hope you are on the mend.

Best,

Mark

Justasheet1 profile image
Justasheet1 in reply toHopeME

Mark,

I guess if you failed ibrutinib then Venetoclax was going to be next anyhow. Might as well pair it up with Duvelisib and maybe throw in obina.

I’m a little over a month on ibrutinib after getting obina at MDA. I’ve had the roving joint and muscle pain with swelling but it never lasts more than a week for me. All my labs look normal and my energy is back just in time to house train a new puppy. He’s exhausting me but I’m making progress.

I go back to Houston in a year. Thanks for checking. How are you doing?

Jeff

HopeME profile image
HopeME in reply toJustasheet1

Hello Jeff:

It is good to hear things are well with you. Training a puppy is a lot of work but it is also very rewarding. My dog is coming up on 2-years so we are in a good zone. I’m also doing well. I’m still in remission at about 11- months after BR chemo. I go in for a quarterly check up next month. I’m hoping for another couple of years before I need to make any decisions. At present I feel as good as I have in years. No fatigue, etc. I'm thankful I don’t have to make any treatment decisions today. Enjoying every day as if it were my last.

Justasheet1 profile image
Justasheet1 in reply toHopeME

Mark,

Next Thursday would have been 5 years since beginning BR. If you count the 6 months too, I got almost 5 1/2 years remission from BR even being unmutated and 11q-

I wasn’t completely myself for 2 years so the best is yet to come for you.

PS- I need a puppy sitter. Interested? 😆

Jeff

Jm954 profile image
Jm954Administrator in reply toJustasheet1

PS, there is nothing more life enhancing than a new puppy, they are the best kind of exhaustion

Jackie

Justasheet1 profile image
Justasheet1 in reply toJm954

That’s exactly what the pup told me too. 🐶

Jm954 profile image
Jm954Administrator in reply toJustasheet1

Not necessarily Jeff, if you have certain comorbidities or need anticoagulation then this could move up the ranking but I agree it wouldn't be my first choice until there is more supporting data.

Jackie

Not what you're looking for?

You may also like...

PI3K inhibitors (idelalisib,copanlisib, duvelisib, parsaclisib, umbralisib, zandelisib, ACP-319) in CLL: where do we go from here?

While we have never been as spoiled for treatment choice as we are now, PI3K inhibitor safety is...
CLLerinOz profile image
Administrator

After you stop with ibrutinib - does Sll-CLL come back?

Hello, i am Anja,54, diagnosed with Sll after many years of health problems. I need treatment but...

Optimal Treatment Combinations in the Management of CLL/SLL Jeff Sharman, MD Provided by Clinical Care Options, LLC

Optimal Treatment Combinations in the Management of CLL/SLL Jeff Sharman, MD An installment...
lankisterguy profile image
Volunteer

Is anyone on Duvelisib?

Is anyone on Duvelisib? Can you, please share your experience. Unfortunately my father’s Venclexta...
Aliona06 profile image

Zanubrutinib Bests Bendamustine-Rituximab in Previously Untreated CLL/SLL

The overall response rate was 94.6% in the zanubrutinib arm and 85.3% in the bendamustine-rituximab...
Yalokin profile image